XON7 binds tumor antigens via its Fab; its Fc engages C1q to activate complement (CDC) and Fcγ receptors for ADCC/ADCP, killing antibody‑coated tumor cells. C1q (A chain) is an effector ligand, not a direct target, so cells expressing it are not directly killed.